Exploring N-Propyllysergamide. To explore a different substance…

Name:
N-Propyllysergamide
IUPAC name:
(8β)-6-Methyl-N-propyl-9,10-didehydroergoline-8-carboxamide
ID: 5312 · Formula: C19H23N3O · Molecular weight: 309.405
InChI: InChI=1S/C19H23N3O/c1-3-7-20-19(23)13-8-15-14-5-4-6-16-18(14)12(10-21-16)9-17(15)22(2)11-13/h4-6,8,10,13,17,21H,3,7,9,11H2,1-2H3,(H,20,23)/t13-,17-/m1/s1
LSD
LA-111
N-Methyllysergamide
LAE-32 · N-Ethyllysergamide
Ergonovine
N-Butyllysergamide
LSB · N-Butan-2-yllysergamide
Methergine
N-Pentyllysergamide
N-Pentan-2-yllysergamide
LSP · N-Pentan-3-yllysergamide
N-Hexyllysergamide
N-Hexan-2-yllysergamide
N-Heptyllysergamide
N-Heptan-2-yllysergamide
DAM-57 · N,N-Dimethyllysergamide
N-Ethyl-N-methyllysergamide
LAMPA · LMP
LA-Me/iso · MIPLA
5328
N-Ethyl-N-propyllysergamide
N,N-Dipropyllysergamide
DIPLA · N,N-Diisopropyllysergamide
DAL
5334
LSH
IPLA · N-Isopropyllysergamide
EIPLA · N-Ethyl-N-isopropyllysergamide
LA-CH2CF3
5083
LA-MeO
LA-Pyr · LPD-824
5336
LA-Pip
LA-Morph · LSM-775
LA-SS-Az
LA-Cispyr
LA-RR-Az
LA-RS-Az
LA-Aziridine
12-MeO-6-Me-Ergoline
5705
5707
6-Me-Ergoline
Descarboxylysergic acid
N-Ethyl-N-methyllysergamide
MLA-74
nor-LSD
IPLA · N-Isopropyllysergamide
LSD
LA-111
N-Methyllysergamide
LAE-32 · N-Ethyllysergamide
Ergonovine
N-Butyllysergamide
LSB · N-Butan-2-yllysergamide
Methergine
N-Pentyllysergamide
N-Pentan-2-yllysergamide
LSP · N-Pentan-3-yllysergamide
N-Hexyllysergamide
N-Hexan-2-yllysergamide
N-Heptyllysergamide
N-Heptan-2-yllysergamide
DAM-57 · N,N-Dimethyllysergamide
N-Ethyl-N-methyllysergamide
LAMPA · LMP
LA-Me/iso · MIPLA
5328
N-Ethyl-N-propyllysergamide
N,N-Dipropyllysergamide
DIPLA · N,N-Diisopropyllysergamide
DAL
5334
LSH
IPLA · N-Isopropyllysergamide
EIPLA · N-Ethyl-N-isopropyllysergamide
LA-CH2CF3
5083
LA-MeO
LA-Pyr · LPD-824
5336
LA-Pip
LA-Morph · LSM-775
LA-SS-Az
LA-Cispyr
LA-RR-Az
LA-RS-Az
LA-Aziridine
12-MeO-6-Me-Ergoline
5705
5707
6-Me-Ergoline
Descarboxylysergic acid
N-Ethyl-N-methyllysergamide
MLA-74
nor-LSD
IPLA · N-Isopropyllysergamide
22 November 2017 · Creative Commons BY-NC-SA ·